Violich Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.58M Sell
44,263
-3,434
-7% -$307K 0.5% 36
2026
Q1
$3.43M Sell
47,697
-2,300
-5% -$177K 0.4% 40
2025
Q4
$3.97M Sell
49,997
-6,267
-11% -$494K 0.44% 38
2025
Q3
$4.24M Buy
56,264
+1,850
+3% +$127K 0.5% 35
2025
Q2
$3.75M Sell
54,414
-6,817
-11% -$447K 0.53% 35
2025
Q1
$4.15M Sell
61,231
-2,276
-4% -$136K 0.56% 34
2024
Q4
$2.85M Sell
63,507
-73,478
-54% -$4.12M 0.37% 40
2024
Q3
$8.61M Sell
136,985
-20,838
-13% -$1.22M 1.12% 23
2024
Q2
$9.32M Sell
157,823
-59,531
-27% -$3.72M 1.26% 22
2024
Q1
$17.3M Buy
217,354
+4,412
+2% +$337K 2.48% 11
2023
Q4
$16.8M Sell
212,942
-15,446
-7% -$1.1M 2.73% 10
2023
Q3
$15.9M Sell
228,388
-14,517
-6% -$1.03M 2.72% 11
2023
Q2
$16.8M Sell
242,905
-10,317
-4% -$734K 2.71% 10
2023
Q1
$18.8M Sell
253,222
-6,645
-3% -$557K 3.21% 8
2022
Q4
$24.2M Sell
259,867
-791
-0.3% -$76.3K 4.3% 7
2022
Q3
$24.9M Sell
260,658
-57
-0% -$5.64K 4.68% 7
2022
Q2
$24.2M Sell
260,715
-1,666
-0.6% -$163K 4.23% 7
2022
Q1
$26.6M Sell
262,381
-886
-0.3% -$93.1K 3.92% 7
2021
Q4
$27.2M Sell
263,267
-475
-0.2% -$43.9K 3.9% 7
2021
Q3
$22.4M Buy
263,742
+424
+0.2% +$35.5K 3.6% 7
2021
Q2
$22M Sell
263,318
-598
-0.2% -$49K 3.69% 7
2021
Q1
$19.9M Buy
263,916
+6,393
+2% +$466K 3.58% 7
2020
Q4
$17.6M Sell
257,523
-6,624
-3% -$431K 3.4% 7
2020
Q3
$15.4M Sell
264,147
-3,744
-1% -$233K 3.25% 8
2020
Q2
$17.4M Buy
267,891
+1,025
+0.4% +$64.5K 3.81% 7
2020
Q1
$15.8M Buy
266,866
+7,451
+3% +$497K 4.24% 7
2019
Q4
$19.3M Buy
259,415
+4,033
+2% +$283K 4.2% 7
2019
Q3
$16.1M Buy
255,382
+30,881
+14% +$1.83M 3.88% 7
2019
Q2
$12.2M Buy
224,501
+526
+0.2% +$28.3K 3.01% 9
2019
Q1
$12.1M Buy
223,975
+14,351
+7% +$886K 3.06% 9
2018
Q4
$13.7M Buy
209,624
+50,469
+32% +$3.77M 3.9% 8
2018
Q3
$12.5M Buy
159,155
+2,425
+2% +$173K 2.86% 12
2018
Q2
$10.1M Buy
156,730
+3,160
+2% +$208K 2.54% 12
2018
Q1
$9.55M Sell
153,570
-4,550
-3% -$326K 2.56% 13
2017
Q4
$11.5M Buy
158,120
+3,025
+2% +$220K 2.92% 11
2017
Q3
$12.6M Buy
155,095
+2,785
+2% +$220K 3.44% 10
2017
Q2
$12.3M Buy
152,310
+3,110
+2% +$246K 3.58% 8
2017
Q1
$11.7M Hold
149,200
3.54% 9
2016
Q4
$11.5M Buy
149,200
+27,295
+22% +$2.21M 3.54% 8
2016
Q3
$10.8M Buy
121,905
+2,575
+2% +$243K 3.8% 7
2016
Q2
$11.4M Buy
119,330
+24
+0% +$2.39K 3.61% 7
2016
Q1
$12.4M Buy
119,306
+2,000
+2% +$194K 3.98% 7
2015
Q4
$11.5M Buy
117,306
+640
+0.5% +$62.7K 3.8% 7
2015
Q3
$11.3M Sell
116,666
-75
-0.1% -$7.88K 3.94% 6
2015
Q2
$12.2M Buy
116,741
+100
+0.1% +$10.2K 4% 6
2015
Q1
$12M Sell
116,641
-414
-0.4% -$41.9K 3.91% 6
2014
Q4
$11.3M Buy
117,055
+1,535
+1% +$135K 3.58% 7
2014
Q3
$9.19M Buy
115,520
+3,062
+3% +$241K 2.99% 7
2014
Q2
$8.48M Sell
112,458
-662
-0.6% -$50K 2.83% 9
2014
Q1
$8.47M Sell
113,120
-100
-0.1% -$7.06K 2.95% 8
2013
Q4
$8.1M Buy
113,220
+1,769
+2% +$114K 2.91% 9
2013
Q3
$6.33M Buy
111,451
+625
+0.6% +$37.2K 2.47% 11
2013
Q2
$6.34M Buy
+110,826
New +$6.42M 2.57% 11

Other funds holding CVS

Violich Capital Management's CVS Position: Q2 2026 in Review

Violich Capital Management reduced its CVS Health (CVS) stake by 7.2% in Q2 2026, selling an estimated $307K and leaving 44,263 shares worth $4.58M. The position accounts for 0.5% of the portfolio, ranked #36.

Violich Capital Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.2M in Q4 2021. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Violich Capital Management held 44,263 shares of CVS Health worth $4.58M as of Q2 2026.
  • Violich Capital Management sold 3,434 CVS Health shares in Q2 2026, an estimated $307K.
  • CVS Health made up 0.5% of Violich Capital Management's portfolio in Q2 2026, its #36 holding.
  • Violich Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Violich Capital Management's CVS Health position peaked at $27.2M in Q4 2021.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Violich Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.